Key Takeaways From MetLife Analyst Ratings


In the preceding three months, 6 analysts have released ratings for MetLife MET, presenting a wide array of perspectives from bullish to bearish.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 6 0 0 0
Last 30D 0 1 0 0 0
1M Ago 0 4 0 0 0
2M Ago 0 1 0 0 0
3M Ago 0 0 0 0 0

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $84.67, a high estimate of $87.00, and a low estimate of $82.00. This upward trend is evident, with the current average reflecting a 3.47% increase from the previous average price target of $81.83.

Investigating Analyst Ratings: An Elaborate Study

The standing of MetLife among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Ryan Krueger Keefe, Bruyette & Woods Lowers Outperform $86.00 $87.00
John Barnidge Piper Sandler Lowers Overweight $82.00 $85.00
Nigel Dally Morgan Stanley Raises Overweight $82.00 $80.00
Elyse Greenspan Wells Fargo Raises Overweight $86.00 $83.00
Ryan Krueger Keefe, Bruyette & Woods Raises Outperform $87.00 $82.00
John Barnidge Piper Sandler Raises Overweight $85.00 $74.00

Key Insights:

  • Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to MetLife. This information provides a snapshot of how analysts perceive the current state of the company.
  • Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of MetLife compared to the broader market.
  • Price Targets: Analysts navigate through adjustments in price targets, providing estimates for MetLife's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of MetLife's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on MetLife analyst ratings.

Unveiling the Story Behind MetLife

MetLife is one of the largest life insurers in the us by assets and provides a variety of insurance and financial services products. The company is organized into five segments: us, Asia, Latin America, EMEA, and MetLife Holdings. The U.S. business contributes around 50% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 22% of earnings and is mainly composed of the Japan business with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile with the Latin America segment contributing around 13% of earnings. The EMEA and the MetLife segments contribute around 4% and 11% of earnings, respectively.

Unraveling the Financial Story of MetLife

Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.

Revenue Growth: MetLife displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately 2.89%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.

Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 5.03%, the company may need to address challenges in effective cost control.

Return on Equity (ROE): MetLife's ROE excels beyond industry benchmarks, reaching 2.73%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): MetLife's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.12%, the company showcases efficient use of assets and strong financial health.

Debt Management: MetLife's debt-to-equity ratio surpasses industry norms, standing at 0.67. This suggests the company carries a substantial amount of debt, posing potential financial challenges.

How Are Analyst Ratings Determined?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Price Target
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!